NeuroPace Falls 37% on Nov. 13 After Guidance Cut and Three Downgrades
NPCE traded between $5.46 and $7.71 in the Nov. 13 regular session on 5.79 million shares, against a 10-day average of 149,551. It closed far below its one-month low after a revenue miss and a lower 2026 forecast.


